<DOC>
	<DOCNO>NCT01737255</DOCNO>
	<brief_summary>This study aim explore use whole body MRI early cancer detection TP53 mutation carrier population control , hypothesis cancer detect TP53 mutation carrier group . A secondary end-point number incidental finding detect subsequent investigation require . A series questionnaire use assess psychological impact screen study control group .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Screening Li Fraumeni Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Li-Fraumeni Syndrome</mesh_term>
	<criteria>Carrier germline TP53 mutation , view geneticist , know low penetrance OR nonrelated individual personal history malignancy first degree relative diagnose malignancy age 50 year Please note , TP53 carrier cohort complete longer open recruitment Age 18 60 Able give inform consent Individual low penetrance TP53 mutation Individual TP53 variant unknown significance . Previous malignancy diagnose &lt; 5 year ago TP53 carrier ( except nonmelanomatous skin cancer cervical CIS ) Previous history malignancy nonrelated control ( except nonmelanomatous skin cancer cervical CIS ) Current symptom suggestive malignancy Contraindication MRI ( nonMR compatible metal implant ) specify standard MR safety checklist Claustrophobia ECOG performance status &gt; 2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Li-Fraumeni Syndrome</keyword>
	<keyword>Whole Body Magnetic Resonance Imaging</keyword>
	<keyword>TP53</keyword>
	<keyword>Psychological Impact</keyword>
</DOC>